Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ICH Urged to Allow for Bioaccessibility in Metal Impurities Standards

This article was originally published in The Gold Sheet

Executive Summary

The world’s leading drug regulatory authorities aim to agree in a June ICH meeting on final standards for elemental impurities like arsenic, lead, cadmium and mercury. Industry has some ideas on what they should decide.


Related Content

ICH and USP Agree to Harmonize Metal Impurity Limits
Restraint Advised in Testing for Elemental Impurities
As ICH Q3D Metal Impurity Limits Near, Industry Worries What New Tests May Find
FDA Offers More Flexibility on Residual Solvents in Generic Drug Applications





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts